CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc. (CARM) Stock Price, Quote, News & History

CARMOTCEM
$0.00250
-0.15-98.38%
Last update: Aug 11, 9:30 AM
Loading...

Key Statistics

Open
-
Close
-
Volume / Avg.
312.00 / 28.29K
Day Range
- - -
52 Wk Range
0.00 - 0.56
Market Cap
-
P/E Ratio
0.01
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
1

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-22.42M
Investing Cash Flow (TTM)
687.00K
Financing Cash Flow (TTM)
-2.38M
Free Cash Flow (TTM)
-22.42M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-24.10M

Analyst Rating and Forecast

12345
3.1
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$1.91M
PE Ratio (TTM)
0.01
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
0.00
PB Ratio (TTM)
-
Earnings Yield % (TTM)
7600.00%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
0.01
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$0.02

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$515.00K
Total Cash
$2.78M
Debt to Equity
-
Issuance of Debt (TTM)
-$515.00K
Repayment of Debt (TTM)
-$515.00K

Key Statistics

Open
-
Close
-
Volume / Avg.
312.00 / 28.29K
Day Range
- - -
52 Wk Range
0.00 - 0.56
Market Cap
-
P/E Ratio
0.01
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and oth...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc. (CARM) stock?

A

You can purchase shares of CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc. (OTCEM:CARM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc. (CARM) competitors?

A

There are no as such competitors for CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc..

Q

What is the forecast, or price target, for CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc. (CARM) stock?

A

CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc. has a consensus price target of $7.34.

Q

What is the current price for CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc. (CARM)?

A

The stock price for CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc. (OTCEM: CARM) is $0.0025 last updated August 11, 2026 at 9:30 AM EDT.

Q

Does CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc. (CARM) pay a dividend?

A

There are no upcoming dividends for CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc..

Q

When is CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc. (OTCEM:CARM) reporting earnings?

A

CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc. does not have any upcoming earnings scheduled.

Q

Is CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc. (CARM) going to split?

A

There is no upcoming split for CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc..

Q

What sector and industry does CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc. (CARM) operate in?

A

CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.